semaglutide novo nordisk patent Whoops! novonordisk will lose its protection on semaglutide, which is sold as #Ozempic and #Wegovy, in Canada after not paying a nominal maintenance fee years before it became a blockbuster drug Patent expires next year: Novo
Description
This injectable medication, originally developed for managing type 2 diabetes, has been shown to aid in significant weight loss for individuals struggling with obesity
The hormone stimulates red blood cell production, which improves oxygen delivery but can thicken blood excessively
)
Yes, Aetna generally covers Ozempic when prescribed for type 2 diabetes and other FDA-approved indications
They are more likely to explore case studies, ingredient profiles, and brand histories before making a decision

The market is projected to record a CAGR of 17.7% from 2026 to 2033

[DOI] [PubMed] [Google Scholar] 76.Goldspink DA, Lu VB, Billing LJ, Larraufie P, Tolhurst G, Gribble FM, Reimann F
